Aethlon Medical FCF/Dettes

Que fait Aethlon Medical ? Aethlon Medical, Inc. generates revenue through its therapeutic and diagnostic segments. The Aethlon segment focuses on the Aethlon Hemopurifier, a device targeting circulating viruses and tumor-secreted exosomes for oncology treatment. The ESI segment, representing diagnostic activities, develops exosome-based product candidates via its subsidiary Exosome Sciences, Inc. (Exosome) for diagnosing neurological disorders and cancer. Customers include healthcare providers seeking innovative treatments for viral infections and cancer progression. The Aethlon Hemopurifier eliminates circulating viruses and exosomes by shedding glycoproteins, addressing both infectious diseases and oncology needs. Exosome Sciences, Inc. (Exosome) develops diagnostic tools using exosomes to monitor neurological conditions and cancer, targeting healthcare institutions and research partners. Revenue streams come from therapeutic device sales and diagnostic product development under the Aethlon and ESI segments. Aethlon Medical, Inc. operates through two business segments: Aethlon for therapeutic products like the Hemopurifier and ESI for diagnostic solutions through Exosome Sciences, Inc. (Exosome). The company's lead product, the Aethlon Hemopurifier, is sold to healthcare providers for treating viral pathogens and cancer metastasis, while Exosome develops exosome-based diagnostics for neurological disorders and cancer monitoring. The firm's revenue is derived from these two segment activities without mentioning external partners or additional financial details. Aethlon Medical est l'une des entreprises les plus populaires sur Eulerpool.